Elefant Dov
- SEC CIK
- 0001326487
Latest role at each company
- FEMY FEMASYS INCChief Financial Officeras of Aug 11, 2026
- CLRB Cellectar Biosciences, Inc.Chief Financial Officeras of Jan 27, 2022
Trades
Every Form 4 that lists Elefant Dov as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| FEMYFEMASYS INC | Aug 11, 20268:37 PM ET | Aug 7, 2026 | Elefant DovChief Financial Officer | PPurchaseCommon Stock | +15.63K | $3.20 | +$50K | 15.63K | New position | SEC |